Cargando…

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States

The renal status of patients with bone metastases secondary to solid tumors and their treatment with nephrotoxic agents is not well characterized. This retrospective study analyzed electronic medical records data from US-based oncology clinics to identify adult (age ≥18) solid tumor patients with fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arellano, Jorge, Hernandez, Rohini K, Wade, Sally W, Chen, Kristina, Pirolli, Melissa, Quach, David, Quigley, Jane, Liede, Alexander, Shahinian, Vahakn B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430264/ https://www.ncbi.nlm.nih.gov/pubmed/25663171 http://dx.doi.org/10.1002/cam4.403

Ejemplares similares

Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States
por: Hernandez, Rohini K., et al.
Publicado: (2018)

Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States
por: Hernandez, Rohini K, et al.
Publicado: (2015)

Prevalence of hypercalcemia among cancer patients in the United States
por: Gastanaga, Victor M., et al.
Publicado: (2016)

International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
por: Liede, Alexander, et al.
Publicado: (2016)

Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States
por: Qian, Yi, et al.
Publicado: (2017)

The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model
por: Wertman, Jaime N, et al.
Publicado: (2020)

Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent
por: Pirker, Robert, et al.
Publicado: (2012)

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
por: McGrath, Leah J., et al.
Publicado: (2018)

Characterization of the immune microenvironment in brain metastases from different solid tumors
por: Jiang, Jinling, et al.
Publicado: (2020)

Validation of International Classification of Diseases coding for bone metastases in electronic health records using technology-enabled abstraction
por: Liede, Alexander, et al.
Publicado: (2015)

Longitudinal patterns of bone-targeted agent use among patients with solid tumors and bone metastases in the United States
por: Qian, Yi, et al.
Publicado: (2017)

Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer
por: Shahinian, Vahakn B, et al.
Publicado: (2015)

Clinical landscape of cancer metastases
por: Riihimäki, Matias, et al.
Publicado: (2018)

Cardiovascular events in cancer patients with bone metastases—A Danish population‐based cohort study of 23,113 patients
por: Asdahl, Peter H., et al.
Publicado: (2021)

Nephrotoxicity of recent anti-cancer agents
por: Lameire, Norbert
Publicado: (2014)

The predictive value of serum lipids for eye metastases in male nasopharyngeal carcinoma patients
por: Xie, Zhen, et al.
Publicado: (2020)

Validation of algorithms to detect distant metastases in men with prostate cancer using routine registry data in Denmark
por: Ehrenstein, Vera, et al.
Publicado: (2015)

Pharmacological agents for the prevention of colistin-induced nephrotoxicity
por: Mirjalili, Mahtabalsadat, et al.
Publicado: (2022)

Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer
por: Kuo, Yong-fang, et al.
Publicado: (2008)

Prognostic value of miR-142 in solid tumors: a meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2021)

Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice
por: Pieper, Alexander A, et al.
Publicado: (2021)

Development and validation of a nomogram to predict synchronous lung metastases in patients with ovarian cancer: a large cohort study
por: Yuan, Yufei, et al.
Publicado: (2020)

Considering renal risk while managing cancer
por: Shahinian, Vahakn B, et al.
Publicado: (2017)

Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity
por: Ojha, Shreesh, et al.
Publicado: (2016)

Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents
por: Hong, Min Hee
Publicado: (2021)

S-nitrosothiols and H(2)S donors: Potential chemo-therapeutic agents in cancer
por: Reis, Adriana Karla Cardoso Amorim, et al.
Publicado: (2019)

In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer
por: Hill, Dawson, et al.
Publicado: (2023)

Variability in the reported management of pulmonary metastases in osteosarcoma
por: Bhattasali, Onita, et al.
Publicado: (2015)

Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases
por: Yang, Jing, et al.
Publicado: (2016)

High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
por: Yang, Xiaoqi, et al.
Publicado: (2020)

Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors
por: Qian, Yi, et al.
Publicado: (2016)

Midlife brain metastases in the United States: Is male at risk?
por: Che, Wenqiang, et al.
Publicado: (2022)

Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study
por: Chou, Yung‐Chih, et al.
Publicado: (2017)

20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial–mesenchymal transition
por: Yuan, Yihang, et al.
Publicado: (2020)

High frequency of lobular breast cancer in distant metastases to the orbit
por: Raap, Mieke, et al.
Publicado: (2015)

An analysis of the relationship between metastases and cachexia in lung cancer patients
por: Shiono, Masatoshi, et al.
Publicado: (2016)

Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma
por: Hagemans, J. A. W., et al.
Publicado: (2019)

Umbilical metastases: Real‐world data shows abysmal outcome
por: Hugen, Niek, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases
por: Schlam, Ilana, et al.
Publicado: (2022)

Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis
por: Hussain, Arif, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d7rfofi36b05qque8uqfh1o36g